强制许可作为专利药品的价格控制和供应政策:在韩国是一种可能的替代方案吗?

Jinok Byeon, Jung-Hoon Chung
{"title":"强制许可作为专利药品的价格控制和供应政策:在韩国是一种可能的替代方案吗?","authors":"Jinok Byeon, Jung-Hoon Chung","doi":"10.4332/KJHPA.2010.20.1.064","DOIUrl":null,"url":null,"abstract":"and life threatening diseases. The effective response regarding to pandemic situation requests collaborative and unbiased provisions of all countries in the world, however, sometimes patent monopoly may hinder the efforts. Compulsory licensing has been considered to be a useful alternative to the abuse of patent rights. However, the Korean experiences of compulsory licensing have left some controversial issues in connection with the availability of it in Korea. ‘Flexibility’ allowed in TRIPS and Doha Declaration has not come into effect in Korea for several reasons. Although the situation shows the limitations of compulsory licensing as a pharmaceutical supply policy, it is clear that compulsory licensing still has the possibilities of enhancing the access to medicines of all countries in need. Through searching the institutionalization process and experiments of compulsory licensing in Korea, this article explores the possibilities and the limits.","PeriodicalId":253456,"journal":{"name":"Korean Journal of Health Policy and Administration","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2010-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Compulsory Licensing as a price control and supply policy of patented drugs : Is it a possible alternative in South Korea?\",\"authors\":\"Jinok Byeon, Jung-Hoon Chung\",\"doi\":\"10.4332/KJHPA.2010.20.1.064\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"and life threatening diseases. The effective response regarding to pandemic situation requests collaborative and unbiased provisions of all countries in the world, however, sometimes patent monopoly may hinder the efforts. Compulsory licensing has been considered to be a useful alternative to the abuse of patent rights. However, the Korean experiences of compulsory licensing have left some controversial issues in connection with the availability of it in Korea. ‘Flexibility’ allowed in TRIPS and Doha Declaration has not come into effect in Korea for several reasons. Although the situation shows the limitations of compulsory licensing as a pharmaceutical supply policy, it is clear that compulsory licensing still has the possibilities of enhancing the access to medicines of all countries in need. Through searching the institutionalization process and experiments of compulsory licensing in Korea, this article explores the possibilities and the limits.\",\"PeriodicalId\":253456,\"journal\":{\"name\":\"Korean Journal of Health Policy and Administration\",\"volume\":\"20 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Korean Journal of Health Policy and Administration\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4332/KJHPA.2010.20.1.064\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Journal of Health Policy and Administration","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4332/KJHPA.2010.20.1.064","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

以及危及生命的疾病。有效应对大流行病需要世界各国的合作和公正的规定,但有时专利垄断可能会阻碍这种努力。强制许可被认为是对滥用专利权的一种有益的替代办法。然而,韩国强制许可的经验留下了一些与韩国强制许可的可用性有关的有争议的问题。TRIPS和多哈宣言中规定的“灵活性”在韩国没有生效,这是有原因的。虽然这种情况显示出强制许可作为一项药品供应政策的局限性,但很明显,强制许可仍然有可能增加所有有需要的国家获得药品的机会。本文通过对韩国强制许可制度的制度化进程和实践的梳理,探讨了韩国强制许可制度的可行性和局限性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Compulsory Licensing as a price control and supply policy of patented drugs : Is it a possible alternative in South Korea?
and life threatening diseases. The effective response regarding to pandemic situation requests collaborative and unbiased provisions of all countries in the world, however, sometimes patent monopoly may hinder the efforts. Compulsory licensing has been considered to be a useful alternative to the abuse of patent rights. However, the Korean experiences of compulsory licensing have left some controversial issues in connection with the availability of it in Korea. ‘Flexibility’ allowed in TRIPS and Doha Declaration has not come into effect in Korea for several reasons. Although the situation shows the limitations of compulsory licensing as a pharmaceutical supply policy, it is clear that compulsory licensing still has the possibilities of enhancing the access to medicines of all countries in need. Through searching the institutionalization process and experiments of compulsory licensing in Korea, this article explores the possibilities and the limits.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信